GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 127 filers reported holding GOSSAMER BIO INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,990 | +93.0% | 91,246 | +178.0% | 0.00% | – |
Q2 2023 | $39,382 | -85.6% | 32,818 | -84.9% | 0.00% | – |
Q1 2023 | $273,488 | -42.9% | 217,054 | -1.7% | 0.00% | – |
Q4 2022 | $479,214 | -85.0% | 220,836 | -17.4% | 0.00% | -100.0% |
Q3 2022 | $3,203,000 | +98.3% | 267,340 | +38.6% | 0.00% | – |
Q2 2022 | $1,615,000 | -18.4% | 192,890 | -15.4% | 0.00% | – |
Q1 2022 | $1,979,000 | -23.3% | 228,023 | -0.1% | 0.00% | – |
Q4 2021 | $2,581,000 | -10.0% | 228,196 | -0.0% | 0.00% | -100.0% |
Q3 2021 | $2,868,000 | +67.8% | 228,202 | +8.4% | 0.00% | – |
Q2 2021 | $1,709,000 | -21.1% | 210,538 | -10.1% | 0.00% | – |
Q1 2021 | $2,167,000 | -5.4% | 234,275 | -1.1% | 0.00% | – |
Q4 2020 | $2,291,000 | -18.4% | 236,833 | +4.7% | 0.00% | -100.0% |
Q3 2020 | $2,807,000 | -2.4% | 226,183 | +2.2% | 0.00% | 0.0% |
Q2 2020 | $2,877,000 | +61.6% | 221,292 | +26.2% | 0.00% | 0.0% |
Q1 2020 | $1,780,000 | -36.1% | 175,381 | -1.7% | 0.00% | 0.0% |
Q4 2019 | $2,787,000 | +2.4% | 178,345 | +10.0% | 0.00% | 0.0% |
Q3 2019 | $2,721,000 | +16.5% | 162,078 | +53.9% | 0.00% | 0.0% |
Q2 2019 | $2,335,000 | +112.1% | 105,292 | +107.2% | 0.00% | – |
Q1 2019 | $1,101,000 | – | 50,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |